Marvell Technology Group (MRVL) Coverage Resumed as Buy at Auriga

Marvell Technology Group (MRVL) has been re-initiated today with coverage from the research analysts at Auriga.  Auriga begins this new coverage of Marvell Technology with an initial price target set at $18 dollars and rates performance of ‘MRVL’ as “buy.”  Auriga notes shares of Marvell are valued at an attractive price.  Despite the “buy” rating, shares of MRVL are down during intraday trading and have overall been on a bearish retrace post-gap of May 27th, 2011.

Marvell Technology Group is slated to release their next earnings report on August 25th, 2011 and is estimated to post EPS of 36 cents.  Their last earnings report was released on May 26th, 2011 and announced EPS of 29 cents with revenue totaling $802 million which was down -6.3 %year to year.  MRVL is currently trading below its 50 & 200-day moving averages and 2011 is currently a down year for the company.

Marvell Technology Group is one of the world’s largest fabless semiconductor providers of high-performance application-specific standard products.  The company has market capitalization of $9,640,000,000 and 650,500,000 shares outstanding.  MRVL has a 52-week high of $22.01 with the low being $13.87 dollars.

Latest News

Recro Pharma Inc  Expected to Post Earnings of -$0.75 Per Share
Recro Pharma Inc Expected to Post Earnings of -$0.75 Per Share
Analysts Anticipate Paylocity Holding Corp  to Announce $0.24 Earnings Per Share
Analysts Anticipate Paylocity Holding Corp to Announce $0.24 Earnings Per Share
La Jolla Pharmaceutical  Expected to Announce Quarterly Sales of $7.12 Million
La Jolla Pharmaceutical Expected to Announce Quarterly Sales of $7.12 Million
Webcoin Market Cap Tops $168,665.00
Webcoin Market Cap Tops $168,665.00
StockChain 24-Hour Trading Volume Reaches $73,685.00
StockChain 24-Hour Trading Volume Reaches $73,685.00
$2.03 EPS Expected for DXC Technology Co  This Quarter
$2.03 EPS Expected for DXC Technology Co This Quarter


© 2006-2018 Ticker Report